價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2024-12-27 |
英文名稱:Research Grade Etigilimab (DHH72402) | CAS:2044984-83-8 |
純度規(guī)格: PAGE:>95% | 產(chǎn)品類別: 藥物對照抗體 |
抗體名: Research Grade Etigilimab (DHH72402) | 靶點: VSTM3, TIGIT |
宿主: Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Research Grade Etigilimab (DHH72402) |
Catalog No.
DHH72402
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
Q495A1
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
OMP-313M32, CAS: 2044984-83-8
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
維百奧(北京)生物科技有限公司
|
2024-12-30 | |
詢價 |
碧云天生物技術(shù)有限公司
|
2024-12-25 | ||
詢價 |
VIP4年
|
武漢艾美捷科技有限公司
|
2024-12-20 |